Story
GE HealthCare Stock Surges After Q2 Earnings and Revenue Beat
Summary
Shares of the medical technology firm jumped after it reported second-quarter adjusted earnings and revenue that surpassed analyst expectations, supported by record order growth and a strong backlog.
GE HealthCare Technologies (GEHC) shares surged more than 12% in pre-market trading after the company announced second-quarter financial results that exceeded analyst forecasts for both profit and sales. The strong performance was driven by robust growth in its imaging and pharmaceutical diagnostics segments and a record level of new orders.
Strong Q2 Results Beat Expectations
For the quarter ended June 30, GE HealthCare reported adjusted earnings of $1.13 per share on revenue of $5.30 billion. This performance topped consensus estimates, which had projected earnings of $1.04 per share on revenue of $5.26 billion, according to Investing.com.
Net income rose to $561 million, an increase from $486 million in the same period last year. The bottom line was notably boosted by $129 million in tariff refunds related to duties that courts had found were improperly collected. The company had previously reaffirmed its full-year profit outlook earlier in the month when it released preliminary Q2 figures.
Operational Highlights and Order Growth
AdPerformance across the company's business units was solid, with imaging device sales growing 7.9% and pharmaceutical diagnostics sales surging 15.6%. Despite this growth, the company noted its adjusted core margin declined by 40 basis points from the prior year, citing inflationary pressures from memory chips, oil, and freight costs.
A key indicator of future performance, the company's order book, showed significant strength. GE HealthCare achieved record organic orders growth, a book-to-bill ratio of 1.15 times, and ended the quarter with a backlog of $23.9 billion. CEO Peter Arduini stated that the quarter demonstrated "record orders and backlog...with orders growth across every segment," providing strong visibility into future revenue.
Market Reaction
The company-specific news was the primary driver of the stock's move, as the broader S&P 500 and Nasdaq indices saw only modest gains. GE HealthCare's stock jumped 12.3% to $72.00 in pre-open trading, a significant rebound from its 52-week low of $58.75. The decisive earnings beat and strong forward-looking indicators appear to have materially reset investor expectations for the remainder of the year.
Read next
More on Stocks
Summit Therapeutics Stock Soars on $2 Billion AstraZeneca Investment, Cancer Drug Collaboration
Summit Therapeutics shares surged over 20% after AstraZeneca announced a $2 billion strategic investment and a clinical collaboration to test combination cancer therapies, signaling strong confidence in Summit's lead drug candidate.
Hapag-Lloyd Stock Rallies After Second 2026 Profit Guidance Upgrade
Shares in the German shipping giant surged after it significantly raised its full-year earnings forecast for the second time, citing strong demand and favorable spot freight rates.
Smiths News Lifts FY2026 Forecast on Strong Collectables and World Cup Sales
The UK news wholesaler announced it expects full-year results to beat market expectations, driven by a record contribution from the FIFA World Cup and robust demand for collectables, sending its shares higher.
Vinci Shares Tumble to 52-Week Low on French Infrastructure Tax Proposal
Shares in French infrastructure giant Vinci fell sharply after the government proposed a new tax on transport concession operators, prompting analysts to warn of a significant hit to earnings.